Shingles Vaccine
1
month saved from expected timeline
61
ICFs sent to sites per week on average
11
sites that 1nHealth collaborated with
Background
1nHealth partnered with a sponsor for a new Phase 2 on US site-based Phase 2 shingles vaccine study running in 11 sites across the United States.
Study Particulars
Approach
Outcomes
Average ICFs Per Week

Best Performing Creative



How can we help your team with patient recruitment?
Got any questions? Schedule a chat with us by clicking the button below!
©2023 – 1nHealth. All Rights Reserved – Legal Notice & Terms of Service